Bringing the fundamentals into focus…
Back to Belite Bio, Inc
How Belite Bio, Inc stacks up
BLTE · against 220 other Healthcare companies of similar size
Valuation
33/ 100
Near the bottom of its peers.
Ranked #164 of 221 · scores higher than 24% of peers
Bars: peers in each 10-point band of the valuation score18 peers with a valuation score of 30–39, including BLTE · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -1.3% vs peer median 1.5%
- EBITDA yield is not reported, so it is left out of the score.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.6% vs peer median 0.0%
Metric by metric
Position: dot = BLTE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BLTE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 218 reported | -1.8% | 2.6% | 22% | 30% | |
| EBITDA yieldHigher is better · 219 reported | Not reported | 4.7% | — | — | 50% |
| Free cash flow yieldHigher is better · 125 reported | Not reported | 1.2% | — | — | 20% |
| Book yieldHigher is better · 219 reported | 12.7% | 24.5% | 26% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around BLTE| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 159 | 5.2B USD | 37 | 74 | |
| 159 | 8.6B USD | 37 | 30 | |
| 159 | 10.1B USD | 37 | 61 | |
| 163 | 3.1B USD | 36 | 53 | |
| 164 | 6.1B USD | 33 | ||
| 164 | 4.5B USD | 33 | 33 | |
| 164 | 5.6B USD | 33 | 53 | |
| 164 | 8.8B USD | 33 | 50 | |
| 164 | 3.3B USD | 33 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score